ESPR
Esperion TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
ESPR vs peer average
73/100
ESPR vs. peer average (B vs. C)
Grade spread
A 2 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
AMPH is the first available peer comparator.
Amphastar is a loose small-cap commercial pharma comparator by market value; it is more useful for benchmarking commercialization discipline and margin execution than for therapeutic overlap.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ESPR
Esperion Therapeutics
AMPH
Amphastar
Grade
B
D
Momentum
94
8
Value
41
71
Sentiment
46
65
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMPH
ESPR / AMPH
Grade Position
Above peers
ESPR vs. peer average (B vs. C)
73/100
Momentum
94
ESPRValue
41
AMPHSentiment
46
AMPHRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ESPR
AMPH is the first peer returned for this comparison set.